MFDS — authorised 23 May 2014
- Marketing authorisation holder: DURATA THERAPS INTL
- Status: likely_approved
🇰🇷 Dalvance in South Korea
MFDS authorised Dalvance on 23 May 2014
Marketing authorisation
Dalvance in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in South Korea
Frequently asked questions
Is Dalvance approved in South Korea?
Yes. MFDS authorised it on 23 May 2014.
Who is the marketing authorisation holder for Dalvance in South Korea?
DURATA THERAPS INTL holds the South Korean marketing authorisation.